GEODE CAPITAL MANAGEMENT, LLC - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 30 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$520,000
+67.2%
256,322
+17.5%
0.00%
Q1 2022$311,000
+8.7%
218,093
+24.1%
0.00%
Q4 2021$286,000
-37.7%
175,787
+21.9%
0.00%
Q3 2021$459,000
-36.5%
144,177
-1.6%
0.00%
Q2 2021$723,000
-18.3%
146,527
+36.5%
0.00%
Q1 2021$885,000
+555.6%
107,376
+48.6%
0.00%
Q4 2020$135,000
+440.0%
72,244
+145.4%
0.00%
Q3 2020$25,000
-10.7%
29,4390.0%0.00%
Q2 2020$28,000
-3.4%
29,4390.0%0.00%
Q1 2020$29,00029,4390.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 291,973$931,0000.13%
Virtu Financial LLC 43,729$139,0000.01%
Jump Financial, LLC 30,551$97,0000.01%
Hudson Bay Capital Management LP 150,404$480,0000.01%
Paloma Partners Management Co 67,406$215,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 68,100$217,0000.00%
Tower Research Capital LLC (TRC) 31,568$101,0000.00%
Stratos Wealth Partners, LTD. 15,543$50,0000.00%
OPPENHEIMER & CO INC 23,013$73,0000.00%
Cutler Group LLC / CA 3,931$12,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders